In This Article:
Philip Morris International Inc.’s PM shares rallied almost 3.5% in the pre-market session today after reporting robust first-quarter 2025 results. Both top and bottom lines increased year over year and beat the respective Zacks Consensus Estimate. Results were fueled by robust momentum across regions and product categories, including continued momentum in IQOS and ZYN, along with a stable combustibles performance. The company raised its 2025 adjusted earnings per share (EPS) guidance.
First-quarter adjusted EPS came in at $1.69, which increased 12.7% year over year. Excluding currency effects, the adjusted EPS jumped 17.3%. The bottom line beat the Zacks Consensus Estimate of $1.61. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
Net revenues of $9,301 million increased 5.8% on a reported basis and 10.2% on an organic basis. Revenues came ahead of the Zacks Consensus Estimate of $8,946.3 million. The increase in organic revenues was backed by positive pricing variance (mainly driven by elevated combustible tobacco pricing) and favorable volume/mix (attributable to increased smoke-free product volumes), despite a less favorable cigarette mix.
Philip Morris International Inc. Price, Consensus and EPS Surprise
Philip Morris International Inc. price-consensus-eps-surprise-chart | Philip Morris International Inc. Quote
PM’s Quarterly Performance: Key Metrics and Insights
During the first quarter, Philip Morris’ net revenues from combustible products remained flat year over year and increased 3.8% organically. Combustible products delivered volume growth and strong pricing gains, which were partially offset by an unfavorable geographic mix.
Revenues from the smoke-free business increased 15% (up 20.4% on an organic basis) and formed 42% of the company’s total revenues. Within the smoke-free business, inhalable smoke-free products (SFP) were driven by strength in IQOS, while oral SFP was fueled by increased shipment volumes of ZYN.
Total shipment volumes (including heated tobacco units, oral SFP and cigarettes) increased 3.9% to 187.8 billion units in the first quarter.
The adjusted operating income ascended 12.8% (up 16% on an organic basis) to $3,790 million, driven by improved pricing variance and a positive volume/mix, somewhat negated by increased marketing, administration and research costs.
Decoding PM’s Region-Wise Performance
Following the sale of Vectura Group Ltd. on Dec. 31, 2024, the company revised its segment reporting to integrate ongoing Wellness and Healthcare results into the Europe segment. Its first-quarter 2025 financial results reflect this updated segment structure.
Net revenues in the European region grew 3% (up 8.6%) on an organic basis to $3,560 million. This was a result of positive pricing variance and favorable volume/mix. Total HTU and cigarette shipment volumes in the region were almost flat at 48.4 billion units.
In the SSEA, CIS & MEA regions, net revenues increased 3.2% (up 6.5% organically) to $2,743 million on improved pricing variance and favorable volume. Total cigarette and HTU shipment volume in the region rose 4.6% to 90.2 billion units.
In the EA, AU & PMI GTR regions, net revenues grew 2.8% (up 6.5% organically) to $1,731 million on favorable volume/mix. Total shipment volumes in the region rose 5.9% to 28.8 billion units.
Revenues in the Americas rose 27.2% (up 32% on an organic basis) to $1,267 million. This was a result of the positive volume/mix and pricing. Total cigarette and HTU shipment volumes in the Americas remained unchanged at 14.4 billion units.